Login
Subscribe
Take a FREE Trial
About Us
Contact us
RSS
19 June 2013
Search
The Pharma Letter
Home
7 Day Premium Trial
Pharmaceuticals
Biotechnology
Generics
Events
Companies
Drugs
Subscribe
darapladib Articles
Great expectations for GlaxoSmithKline R&D newsflow
13 December 2012
Showing 1-1 of 1 articles
1
Hot Topics
Most Read
US Supreme Court says patent settlement can "sometimes" be illegal
InSite Vision joins Merck & Co and Pfizer in patent infringement law suit against
Highlights of EHA meeting: Novartis' Jakavi; Bristol-Myers and AbbVie's elotuzumab; Janssen's ibrutinib
Daiichi Sankyo files for Japanese approval of Prasugrel
Osteoporosis drug bazedoxifene stops growth of breast cancer cells, even in resistant tumors
US Supreme Court says patent settlement can "sometimes" be illegal
InSite Vision joins Merck & Co and Pfizer in patent infringement law suit against
Highlights of EHA meeting: Novartis' Jakavi; Bristol-Myers and AbbVie's elotuzumab; Janssen's ibrutinib
Daiichi Sankyo files for Japanese approval of Prasugrel
Osteoporosis drug bazedoxifene stops growth of breast cancer cells, even in resistant tumors